Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 May 12;63(8):1254–1256. doi: 10.1007/s11427-020-1669-x

Cell membrane-derived biomimetic nanodecoys for viruses

Xuan Liu 1, Dengfeng Li 1, Gang Liu 1,✉
PMCID: PMC7221333  PMID: 32410090

The content is available as a PDF (841.4 KB).

Acknowledgements

This work was supported by the Major State Basic Research Development Program of China (2017YFA0205201), the National Natural Science Foundation of China (81901876, 81422023 and U1705281), the Fundamental Research Funds for the Central Universities (20720190088 and 20720200019), and the Program for New Century Excellent Talents in University, China (NCET-13-0502).

Footnotes

Compliance and ethics

The author(s) declare that they have no conflict of interest.

References

  1. Bricarello DA, Patel MA, Parikh AN. Inhibiting host-pathogen interactions using membrane-based nanostructures. Trends Biotech. 2012;30:323–330. doi: 10.1016/j.tibtech.2012.03.002. [DOI] [PubMed] [Google Scholar]
  2. Chen S, Liang XJ. Nanobiotechnology and nanomedicine: small change brings big difference. Sci China Life Sci. 2018;61:371–372. doi: 10.1007/s11427-018-9293-2. [DOI] [PubMed] [Google Scholar]
  3. Dehaini D, Fang RH, Zhang L. Biomimetic strategies for targeted nanoparticle delivery. Bioeng Translational Med. 2016;1:30–46. doi: 10.1002/btm2.10004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Guo H, Cai C, Wang B, Zhuo F, Jiang R, Wang N, Li B, Zhang W, Zhu Y, Fan Y, et al. Novel hepacivirus in Asian house shrew, China. Sci China Life Sci. 2019;62:701–704. doi: 10.1007/s11427-018-9435-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Holmes EC, Dudas G, Rambaut A, Andersen KG. The evolution of Ebola virus: Insights from the 2013–2016 epidemic. Nature. 2016;538:193–200. doi: 10.1038/nature19790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327:46–50. doi: 10.1126/science.1174621. [DOI] [PubMed] [Google Scholar]
  7. Liu H, Yang Y, Liu Y, Pan J, Wang J, Man F, Zhang W, Liu G. Melanin-like nanomaterials for advanced biomedical applications: a versatile platform with extraordinary promise. Adv Sci. 2020;7:1903129. doi: 10.1002/advs.201903129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Liu X, Yuan L, Zhang L, Mu Y, Li X, Liu C, Lv P, Zhang Y, Cheng T, Yuan Q, et al. Bioinspired artificial nanodecoys for hepatitis B virus. Angew Chem Int Ed. 2018;57:12499–12503. doi: 10.1002/anie.201807212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Marsh M, Helenius A. Virus entry: open sesame. Cell. 2006;124:729–740. doi: 10.1016/j.cell.2006.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430:242–249. doi: 10.1038/nature02759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Rao L, Wang W, Meng QF, Tian M, Cai B, Wang Y, Li A, Zan M, Xiao F, Bu LL, et al. A biomimetic nanodecoy traps Zika virus to prevent viral infection and fetal microcephaly development. Nano Lett. 2019;19:2215–2222. doi: 10.1021/acs.nanolett.8b03913. [DOI] [PubMed] [Google Scholar]
  12. Shi Y, Xie F, Rao P, Qian H, Chen R, Chen H, Li D, Mu D, Zhang L, Lv P, et al. TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy. J Control Release. 2020;320:304–313. doi: 10.1016/j.jconrel.2020.01.054. [DOI] [PubMed] [Google Scholar]
  13. Wang J, Wang Y, Wang R, Zhang S, Liu X, Liang XJ. Targeted nanoparticles for precise cancer therapy. Sci China Life Sci. 2019;62:1392–1395. doi: 10.1007/s11427-019-9824-0. [DOI] [PubMed] [Google Scholar]
  14. Wei X, Zhang G, Ran D, Krishnan N, Fang RH, Gao W, Spector S A, Zhang L. T-cell-mimicking nanoparticles can neutralize HIV infectivity. Adv Mater. 2018;30:1802233. doi: 10.1002/adma.201802233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Woyessa AB, Mengesha M, Belay D, Tayachew A, Ayele W, Beyene B, Kassa W, Zemelak E, Demissie G, Amare B, et al. Epidemiology of influenza in Ethiopia: findings from influenza sentinel surveillance and respiratory infection outbreak investigations, 2009–2015. BMC Infect Dis. 2018;18:449. doi: 10.1186/s12879-018-3365-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yuan L, Jiang J, Liu X, Zhang Y, Zhang L, Xin J, Wu K, Li X, Cao J, Guo X, et al. HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation. Gut. 2019;68:2044–2056. doi: 10.1136/gutjnl-2018-316091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yuan L, Zhang Y, Liu X, Chen Y, Zhang L, Cao J, Li X, Wang M, Wu K, Zhang J, et al. Agonist c-Met monoclonal antibody augments the proliferation of hiPSC-derived hepatocyte-like cells and improves cell transplantation therapy for liver failure in mice. Theranostics. 2019;9:2115–2128. doi: 10.7150/thno.30009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18035. doi: 10.1038/nrdp.2018.35. [DOI] [PubMed] [Google Scholar]
  19. Zhang X, Zhang Y, Zhang Y, Lv P, Zhang P, Chu C, Mao J, Wang X, Li W, Liu G. Bio-engineered cell membrane nanovesicles as precision theranostics for perihilar cholangiocar-cinoma. Biomater Sci. 2020;8:1575–1579. doi: 10.1039/C9BM02088H. [DOI] [PubMed] [Google Scholar]
  20. Zhang Y, Yu J, Qiang L, Gu Z. Nanomedicine for obesity treatment. Sci China Life Sci. 2018;61:373–379. doi: 10.1007/s11427-017-9257-1. [DOI] [PubMed] [Google Scholar]

Articles from Science China. Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES